BostonGene and the Parker Institute for Cancer Immunotherapy Collaborate to Generate Comprehensive Longitudinal Multi-Omic Data for Predicting Immunotherapy Outcomes
WALTHAM, Mass. & SAN FRANCISCO--(BUSINESS WIRE)--Apr 30, 2024--
Source: eagletribune.com